# Franklin Templeton Holdings Trust: financial statements, quarterly

FGDL · NYSE · CIK 1858258 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/fgdl.md) · [Financials](/companies/fgdl/financials.md) · [Filings](/companies/fgdl/filings.md) · [Insiders](/companies/fgdl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fgdl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(1.3)](/filings/0001193125-24-255734.md) | [6.5](/filings/0001140361-25-004056.md) | [4.2 d](/filings/0001140361-25-024063.md) | [3.2](/filings/0001140361-25-030875.md) | [9.0](/filings/0001140361-25-041929.md) | [(1.9)](/filings/0001140361-26-005775.md) | [24.3 d](/filings/0001140361-26-026742.md) | [10.0](/filings/0001140361-26-033199.md) | [41.5](/filings/0001140361-25-041929.md) | [48.2](/filings/0001140361-26-005775.md) | [32.5 d](/filings/0001140361-26-026742.md) | [(60.3)](/filings/0001140361-26-033199.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [65.0](/filings/0001193125-24-157217.md) | [57.9](/filings/0001193125-24-157221.md) | [62.1](/filings/0001140361-25-024063.md) | [68.5](/filings/0001193125-24-200691.md) | [86.0](/filings/0001193125-24-255734.md) | [108](/filings/0001140361-25-004056.md) | [187](/filings/0001140361-26-026742.md) | [228](/filings/0001140361-25-030875.md) | [377](/filings/0001140361-25-041929.md) | [465](/filings/0001140361-26-005775.md) | [476](/filings/0001140361-26-033199.md) | [415](/filings/0001140361-26-033199.md) |
| Total liabilities | $m | [0.0](/filings/0001193125-24-157217.md) | [0.0](/filings/0001193125-24-157221.md) | [0.0](/filings/0001140361-25-024063.md) | [0.0](/filings/0001193125-24-200691.md) | [0.0](/filings/0001193125-24-255734.md) | [0.0](/filings/0001140361-25-004056.md) | [0.0](/filings/0001140361-26-026742.md) | [0.0](/filings/0001140361-25-030875.md) | [0.0](/filings/0001140361-25-041929.md) | [0.1](/filings/0001140361-26-005775.md) | [0.1](/filings/0001140361-26-033199.md) | [0.0](/filings/0001140361-26-033199.md) |
| Shareholders' equity | $m | [60.0](/filings/0001140361-25-004056.md) | [46.3](/filings/0001140361-25-004056.md) | [46.3](/filings/0001140361-26-026742.md) | [49.4](/filings/0001140361-25-041929.md) | [58.0](/filings/0001140361-26-005775.md) | [81.9](/filings/0001140361-26-005775.md) | [137](/filings/0001140361-26-033199.md) | [167](/filings/0001140361-26-033199.md) | [275](/filings/0001140361-26-005775.md) | [315](/filings/0001140361-26-005775.md) | [293](/filings/0001140361-26-033199.md) | [293](/filings/0001140361-26-033199.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $ | [0.0 d](/filings/0001193125-24-255734.md) | [0.0 d](/filings/0001140361-25-004056.md) | [0.0 d](/filings/0001140361-25-024063.md) | [0.0](/filings/0001140361-25-030875.md) | [0.0 d](/filings/0001140361-25-041929.md) | [0.0 d](/filings/0001140361-26-005775.md) | [0.0 d](/filings/0001140361-26-026742.md) | [0.0](/filings/0001140361-26-033199.md) | [0.0 d](/filings/0001140361-25-041929.md) | [0.0 d](/filings/0001140361-26-005775.md) | [0.0 d](/filings/0001140361-26-026742.md) | [0.0](/filings/0001140361-26-033199.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 7,750,000 at 2026-08-03, from the cover of the [10-Q filed 2026-08-14](/filings/0001140361-26-033199.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.